Article: NAD+ Restores Heart Function in Heart Failure via Ketone Production: Preclinical Findings

PrevNext
Metabolic Health Preclinical

NAD+ Restores Heart Function in Heart Failure via Ketone Production: Preclinical Findings

Synopsis

Heart failure with preserved ejection fraction (HFpEF) is a common form of heart failure with few treatment options. This study found that the heart can make ketones using the enzyme HMGCS2, but its activity is reduced when the enzyme is overly acetylated. Replenishing oxidized NAD+ restored HMGCS2 activity, improved fat metabolism, and rescued heart function in HFpEF. However, in mice lacking HMGCS2 specifically in heart cells, NAD+ restoration could not improve heart function. These results show that HMGCS2 is essential for the benefits of NAD+ therapy in HFpEF, linking ketone production, fat metabolism, and mitochondrial health to heart recovery.

Journal

Circulation Research

Share

Read more

Preclinical

Nicotinamide Riboside Reduces Inflammation in Retinal Degeneration: Preclinical Findings

Synopsis Bright light exposure triggers mitochondrial damage in the retina, releasing double-stranded DNA that activates the cGAS-STING inflammatory pathway and drives microglial pyroptosis, accel...

Read more
Cardiovascular Disease

Nicotinamide Riboside Restores Lipid Handling in Diabetic Heart Disease: Preclinical Findings

Synopsis Excessive lipid droplet buildup and lipotoxicity contribute to diabetic cardiomyopathy (DCM). This study found that lipophagy—the autophagic breakdown of lipid droplets—is impaired in DCM...

Read more